European evidence-based guidelines on pancreatic cystic neoplasms

Evidence-based guidelines on the management of pancreatic cystic neoplasms (PCN) are lacking. This guideline is a joint initiative of the European Study Group on Cystic Tumours of the Pancreas, United European Gastroenterology, European Pancreatic Club, European-African Hepato-Pancreato-Biliary Asso...

Teljes leírás

Elmentve itt :
Bibliográfiai részletek
Szerzők: Kollaborációs szervezet: European Study Group on Cystic Tumours of the Pancreas
Del Chiaro Marco
Besselink Marc B.
Scholten Lianne
Bruno Marco J.
Cahen Djuna L.
Gress Thomas M.
van Hooft Jeanin E.
Lerch Markus M.
Mayerle Julia
Hackert Thilo
Satoi Sohei
Zerbi Alessandro
Cunningham David
Hegyi Péter
et al
Dokumentumtípus: Cikk
Megjelent: 2018
Sorozat:GUT 67 No. 5
Tárgyszavak:
doi:10.1136/gutjnl-2018-316027

mtmt:34043765
Online Access:http://publicatio.bibl.u-szeged.hu/27257
LEADER 02850nab a2200397 i 4500
001 publ27257
005 20241125150547.0
008 230523s2018 hu o 000 eng d
022 |a 0017-5749 
024 7 |a 10.1136/gutjnl-2018-316027  |2 doi 
024 7 |a 34043765  |2 mtmt 
040 |a SZTE Publicatio Repozitórium  |b hun 
041 |a eng 
100 2 |a Kollaborációs szervezet: European Study Group on Cystic Tumours of the Pancreas 
245 1 0 |a European evidence-based guidelines on pancreatic cystic neoplasms  |h [elektronikus dokumentum] /  |c  Kollaborációs szervezet: European Study Group on Cystic Tumours of the Pancreas 
260 |c 2018 
300 |a 789-804 
490 0 |a GUT  |v 67 No. 5 
520 3 |a Evidence-based guidelines on the management of pancreatic cystic neoplasms (PCN) are lacking. This guideline is a joint initiative of the European Study Group on Cystic Tumours of the Pancreas, United European Gastroenterology, European Pancreatic Club, European-African Hepato-Pancreato-Biliary Association, European Digestive Surgery, and the European Society of Gastrointestinal Endoscopy. It replaces the 2013 European consensus statement guidelines on PCN. European and non-European experts performed systematic reviews and used GRADE methodology to answer relevant clinical questions on nine topics (biomarkers, radiology, endoscopy, intraductal papillary mucinous neoplasm (IPMN), mucinous cystic neoplasm (MCN), serous cystic neoplasm, rare cysts, (neo)adjuvant treatment, and pathology). Recommendations include conservative management, relative and absolute indications for surgery. A conservative approach is recommended for asymptomatic MCN and IPMN measuring < 40 mm without an enhancing nodule. Relative indications for surgery in IPMN include a main pancreatic duct (MPD) diameter between 5 and 9.9 mm or a cyst diameter >= 40 mm. Absolute indications for surgery in IPMN, due to the high-risk of malignant transformation, include jaundice, an enhancing mural nodule > 5 mm, and MPD diameter > 10 mm. Lifelong follow-up of IPMN is recommended in patients who are fit for surgery. The European evidence-based guidelines on PCN aim to improve the diagnosis and management of PCN. 
650 4 |a Klinikai orvostan 
700 0 2 |a Del Chiaro Marco  |e aut 
700 0 2 |a Besselink Marc B.  |e aut 
700 0 2 |a Scholten Lianne  |e aut 
700 0 2 |a Bruno Marco J.  |e aut 
700 0 2 |a Cahen Djuna L.  |e aut 
700 0 2 |a Gress Thomas M.  |e aut 
700 0 2 |a van Hooft Jeanin E.  |e aut 
700 0 2 |a Lerch Markus M.  |e aut 
700 0 2 |a Mayerle Julia  |e aut 
700 0 2 |a Hackert Thilo  |e aut 
700 0 2 |a Satoi Sohei  |e aut 
700 0 2 |a Zerbi Alessandro  |e aut 
700 0 2 |a Cunningham David  |e aut 
700 0 2 |a Hegyi Péter  |e aut 
700 0 2 |a et al.  |e aut 
856 4 0 |u http://publicatio.bibl.u-szeged.hu/27257/1/Hegyi.pdf  |z Dokumentum-elérés